MyAverix Finance
TWO · Healthcare
Golden Biotechnology Corporation (4132)
Drug Manufacturers - Specialty & Generic
Golden Biotechnology Corporation (4132) is listed on TWO in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 4132
Golden Biotechnology Corporation (4132) — FAQ
What is 4132's P/E ratio?
The price-to-earnings (P/E) ratio for Golden Biotechnology Corporation (4132) is 18.00 (data as of 2026-03-23).
Does Golden Biotechnology Corporation pay a dividend?
Dividend yield is not available in the current snapshot for Golden Biotechnology Corporation (4132). Check the MyAverix Finance app for the latest dividend data.
What sector is Golden Biotechnology Corporation in?
Golden Biotechnology Corporation (4132) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 4132 listed on?
4132 is listed on TWO.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.